Cargando…
Development of an autophagy activator from Class III PI3K complexes, Tat-BECN1 peptide: Mechanisms and applications
Impairment or dysregulation of autophagy has been implicated in many human pathologies ranging from neurodegenerative diseases, infectious diseases, cardiovascular diseases, metabolic diseases, to malignancies. Efforts have been made to explore the therapeutic potential of pharmacological autophagy...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9511052/ https://www.ncbi.nlm.nih.gov/pubmed/36172279 http://dx.doi.org/10.3389/fcell.2022.851166 |